Karen Fay Ross, MD in Pearl, MS - Pathology

Karen Fay Ross, MD is a Pathology - Forensic Pathology physician based in Pearl, Mississippi. Karen Fay Ross is licensed to practice in Texas (license number J5461) and her current practice location is 215 Allen Stuart Dr, Pearl, Mississippi. She can be reached at her office (for appointments etc.) via phone at (601) 420-9140.

NPI number for Karen Fay Ross is 1295436558 and her current mailing address is Po Box 148, 6213 Sycamore Street, Wilson, Louisiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1295436558.

Contact Information

	Karen Fay Ross, MD
	215 Allen Stuart Dr, Pearl, MS 39208-6060
	(601) 420-9140
	Not Available

Physician's Profile

Full Name	Karen Fay Ross
Gender	Female
Speciality	Pathology - Forensic Pathology
Location	215 Allen Stuart Dr, Pearl, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1295436558
Provider Enumeration Date: 03/14/2023
Last Update Date: 03/14/2023

Medical Identifiers

Medical identifiers for Karen Fay Ross such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1295436558	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZF0201X	Pathology - Forensic Pathology	J5461 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Karen Fay Ross is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Karen Fay Ross, MD Po Box 148, 6213 Sycamore Street, Wilson, LA 70789 Ph: () -	Karen Fay Ross, MD 215 Allen Stuart Dr, Pearl, MS 39208-6060 Ph: (601) 420-9140

News Archive

Educating parents on healthy infant sleep-related behaviors may help prevent childhood obesity

Teaching parents bedtime techniques to encourage healthy sleep habits in their infants may help prevent obesity, according to Penn State College of Medicine researchers. Strong links exist between inadequate sleep and childhood obesity.

Trial investigating "abortion pill reversal" stops due to safety concerns

Scientists are calling for pro-life US states to abolish an unproven medication that supposedly "reverses" medical abortion.

Johnson & Johnson, Crucell announce advanced negotiations for potential public offer

Johnson & Johnson and Crucell N.V. today announced that they are in advanced negotiations for a potential public offer by Johnson & Johnson or an affiliate for all outstanding ordinary shares of Crucell not already held by Johnson & Johnson and its affiliates.

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.

Karen Fay Ross, MD - Pathology in Pearl, MS